Assertion: tetanus's vaccine | /r/MadeOf | tetanus toxoid
Facets:
Source sentences:
text: (1) If Guillain-Barré syndrome occurred within 6 weeks of receipt of prior vaccine containing tetanus toxoid, the risk for Guillain-Barré syndrome may be increased following Diphtheria and Tetanus Toxoids Adsorbed vaccine.
text: The following neurologic illnesses have been reported as temporally associated with vaccine containing tetanus toxoid: neurological complications13 including cochlear lesion,14 brachial plexus neuropathies,14,15 paralysis of the radial nerve,16 paralysis of the recurrent nerve,14 accommodation paresis,
text: The following neurologic illnesses have been reported as temporally associated with vaccines containing tetanus toxoid: neurological complications 14 including cochlear lesion, 15 brachial plexus neuropathies, 14,16 paralysis of the radial nerve, 17 paralysis of the recurrent nerve, 15 accommodation paresis, Guillain-Barré syndrome (GBS), and EEG disturbances with encephalopathy.
text: Some manufacturers state base decision to administer subsequent doses of DTaP, Tdap, or any vaccine containing tetanus toxoid in such patients on careful consideration of potential benefits and possible risks.106
text: If hypersensitivity reaction occurs, no further doses of the vaccine or any other vaccine containing diphtheria toxoid, tetanus toxoid, or pertussis vaccine should be given because of uncertainty regarding which component may have caused the reaction.105 187 192 193 223 224 If further doses are being considered (e.g., for tetanus postexposure prophylaxis), consider consultation with an allergist.187 192 193 223
text: Hib before the age of 1 year, administered at an interval of 1 month (e.g. at the age of 6, 10 and 14 weeks), then a dose of a vaccine containing tetanus toxoid between the age of 12 and 23 months, a dose between the age of 4 to 7 years, then a dose between the age of 12 and 15 years.
text: If Guillain-Barré syndrome occurred within 6 weeks after receipt of a previous dose of tetanus toxoid-containing vaccine, the decision to give subsequent doses of TDVAX or any vaccine containing tetanus toxoid should be based on careful consideration of the potential benefits and possible risks.
text: ADACEL ® (adsorbed vaccine containing tetanus toxoid, reduced diphtheria toxoid and reduced acellular pertussis vaccine),
text: sanofi pasteur Ltd. (Tdap-IPV) BOOSTRIX ® adsorbed vaccine containing tetanus toxoid, reduced diphtheria toxoid and reduced acellular pertussis vaccine), GlaxoSmithKline Inc. (Tdap)
text: At a separate site, the first dose of the age-appropriate form of vaccine containing tetanus toxoid should also be administered.